Monday, December 03, 2007

Ferring pharmaceuticals completes phase III study of degarelix in prostate cancer patients

|More|
Tuesday, October 30, 2007

Superior remission rates for once daily use of Pentasa® (mesalazine) in ulcerative colitis

|More|
Thursday, October 11, 2007

Ferring Pharmaceuticals Forges Worldwide Licensing Agreement for Budesonide MMX™

|More|
Tuesday, September 25, 2007

Ferring Pharmaceuticals Announces Board Changes

|More|
Monday, July 02, 2007

New data demonstrates both cost and efficacy benefit of MENOPUR® compared to recombinant FSH treatment

|More|
Monday, July 02, 2007

Inequality in treatment access remains a key issue for infertile couples across Europe

|More|
 

Print

Mail

© Ferring 2008